Scientists aim to identify the most effective TBS protocols for treating schizophrenia

Schizophrenia, which is characterized by positive symptoms (e.g., hallucinations and delusions), negative symptoms (diminished emotional expressions or avolition), and cognitive impairments (attention deficits and poor learning skills), is a serious mental health condition that affects how individuals think, behave, and perceive the world.

Mankind, Innovent partner for Sintilimab commercialisation in India

Under the agreement, Mankind Pharma will have the exclusive rights to register, import, market, sell, and distribute Sintilimab in India. Credit: Piotr Swat/Shutterstock. Mankind Pharma

December 27, 2024

Opinion | ‘Is It Safe to Hit a Kid in the Head 200 Times?’: What We Heard This Week

“Is it safe to hit a kid in the head 200 times?” — Chris Nowinski, PhD, of the Concussion Legacy Foundation in Boston, on head

September 16, 2024

Beckman Coulter Life Sciences Revolutionizes Nanoparticle Analysis, Enabling Characterization Down To 40 nm With Launch of CytoFLEX nano Flow Cytometer

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.